Clinical trial

Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for…

NCT00099684 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed

Key facts

NCT number NCT00099684
Title Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected Adults
Official title A Pilot Study of the Safety, Efficacy, and Tolerability of Ezetimibe (Zetia) in Combination With Statin Therapy for the Treatment of Elevated LDL Cholesterol in HIV-Infected Subjects
Lead sponsor National Institute of Allergy and Infectious Diseases (NIAID), NIH
Status Completed
Study type Interventional
Conditions HIV Infections
Intervention type Drug
Interventions Ezetimibe
Enrollment 44
Start date Nov 1, 2005
Completion May 1, 2007
First posted Dec 20, 2004
Last update posted Oct 29, 2012
Countries Puerto Rico, United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies